Amniotics AB are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient
Member count: 11-50
Total raised: $6.977596M
Founded date: 2015
Investors 1
Date | Name | Website |
- | Almi Inves... | almi.se |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
12.07.2021 | IPO | $6.977596M | - | news.cisio... |
Mentions in press and media 7
Date | Title | Description | Category | Author | Source |
20.01.2022 | Amniotics ... | Amniotics AB (publ) announced ... | - | - | marketscre... |
20.01.2022 | Amniotics ... | Amniotics AB (publ) (Nasdaq St... | - | - | marketscre... |
12.11.2021 | Interim Re... | Preparing for clinical phase ... | - | - | marketscre... |
27.08.2021 | Amniotics ... | Successful IPO April - June i... | - | - | marketscre... |
12.07.2021 | Stem cell ... | Novel source of stem cells in ... | - | - | en.prnasia... |
12.07.2021 | Stem cell ... | Stem cell therapy company Amni... | - | - | news.cisio... |
12.07.2021 | Amniotics ... | LUND, Sweden, July 12, 2021 /P... | - | - | marketscre... |